Catalyst Communications Company Profile

22:51 EDT 20th June 2018 | BioPortfolio

Catalyst [Kat-a-list] noun: 1. a powerful agent whose action inspires substantial change and the creation of new, different entities. 2. an agent that increases the rate of change in systems. In a constantly evolving world, change is not only inevitable - it's desirable.
New products, services, resellers, partners, staff, customers. Successfully managing these transformations to differentiate yourself from the competition will make a positive impact on your bottom line. That's where Catalyst comes in.We construct individual PR campaigns that recognise your unique vision. Researched, designed and delivered with ingenuity and flair. Executed at speed with passion and creativity. Inspired, focused, technology-related public relations. So you stay ahead of the pack.


Siena CourtThe Broadway
United Kingdom


Phone: 44 (0) 845 226 30 36
Fax: 44 (0) 845 226 31 36

News Articles [462 Associated News Articles listed on BioPortfolio]

A simple catalyst helps to assemble complex molecular frameworks of antifungal agents

(AKSON Russian Science Communication Association) A team of Russian chemists led by Professor Dmitry Perekalin from Nesmeyanov Institute of Organoelement Compounds have recently developed a new rhodiu...

Highly efficient ammonia synthesis catalyst developed

Researchers have discovered that a catalyst of calcium amide with a small amount of added barium (Ba-Ca(NH2)2) with ruthenium nanoparticles immobilized onto it can synthesize ammonia at an efficiency ...

Catalyst seeks FDA nod for Lambert-Eaton myasthenic syndrome therapy

Catalyst Pharmaceuticals filed a new drug application with the FDA seeking approval for Firdapse, or amifampridine, which is  -More- 

Catalyst Pharmaceuticals Announces FDA Acceptance of NDA and Priority Review Status for Firdapse

Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq:CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating, chronic neuromusc...

Catalyst Pharmaceuticals enrols first patient in MSK-002 trial

Catalyst Pharmaceuticals has enrolled the first patient in its MSK-002 trial, a Phase III clinical study evaluating the efficacy and...Read More... The post Catalyst Pharmaceuticals enrols first patie...

In The Spotlight: Catalyst Biosciences

Shares of Catalyst Biosciences Inc. (CBIO) are up an impressive 100% year-to-date in sharp contrast to the NASDAQ Biotechnology Index, which is down nearly 2% during the same period.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Catalyst Biosciences, Inc. - CBIO

NEW YORK, June 18, 2018 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Catalyst Biosciences, Inc. ("Catalyst" or the "Company") (NASDAQ: CBIO). Such investors are ...

New Catalyst Could Lead to Higher Quality Biofuels

ArticleResearchers now believe they have developed a better way to produce biofuels from biowaste by using methane and a new catalyst. Staff Author:&nbs

Drugs and Medications [0 Results]


PubMed Articles [438 Associated PubMed Articles listed on BioPortfolio]

Communications of the median nerve in fetuses.

Communications between the median, ulnar and musculocutaneous nerves in the arm, forearm and hand were reported in adult cadaveric and electrophysiological studies. These communicant branches may lead...

Industrial wastewater advanced treatment via catalytic ozonation with an Fe-based catalyst.

An Fe-based catalyst was used as a heterogeneous catalyst for the ozonation of industrial wastewater, and key operational parameters (pH and catalyst dosage) were studied. The results indicated that t...

Plasma-catalyst hybrid reactor with CeO2/γ-Al2O3 for benzene decomposition with synergetic effect and nano particle by-product reduction.

A dielectric barrier discharge (DBD) catalyst hybrid reactor with CeO2/γ-Al2O3 catalyst balls was investigated for benzene decomposition at atmospheric pressure and 30 °C. At an energy density of ...

Development of a framework catalyst for photocatalytic hydrogen evolution.

The controlled self-assembly of a catalyst module composed of a Rh(ii) paddle-wheel dimer bearing 1,8-naphthalimide-based moieties afforded a novel heterogeneous framework catalyst (FC-1). The framewo...

Sinter-resistant and highly active sub- 5 nm bimetallic Au-Cu nanoparticle catalyst encapsulated in silica for high-temperature carbon monoxide oxidation.

A novel gold-copper based silica encapsulated mixed metal oxide (MMO) core-shell catalyst - with sub 5-nm MMO particles - was successfully synthesized via a reverse micelle process. The SiO2 encapsula...

Clinical Trials [15 Associated Clinical Trials listed on BioPortfolio]

Multi-level Communications and Access Strategies to Improve the Food Environment

The overarching goal of B'More Healthy Retail Rewards (BHRR) is to develop, implement, and evaluate a pilot multi-level communications and pricing intervention to improve access to and con...

HERrespect Evaluation

This study evaluates whether a factory wide intervention, HERrespect, can reduce female garment workers' experiences of intimate partner violence, and experience and/or witnessing of viole...

A SU2C Catalyst® Trial of a PD1 Inhibitor With or Without a Vitamin D Analog for the Maintenance of Pancreatic Cancer

Chemotherapy regimens for pancreatic cancer can now stabilize a patient's cancer and/or place some patients in remission or partial remission. The challenge now is to find options for main...

Improving the Outpatient Referral Process With Electronic Communications

An electronic referral application will be developed and integrated into the existing outpatient information system. The primary goal of this software is to improve the quality and coordi...

The ACHIEVA Study of Enhanced Pharmacist Care on Antidepressant Use and Response

This a comparative study of enhanced pharmacist care and regular care of patients starting on antidepressants. When providing participants with enhanced care pharmacists will use the Healt...

Companies [521 Associated Companies listed on BioPortfolio]

Catalyst Communications

Catalyst [Kat-a-list] noun: 1. a powerful agent whose action inspires substantial change and the creation of new, different entities. 2. an agent that increases the rate of change in systems. ...

Catalyst Health and Technology Partners

Catalyst Health and Technology Partners (“Catalyst”), is a venture capital firm dedicated to helping promising early-stage health care, life science, and technology ventures grow.Catalyst is focus...

General Catalyst Partners

General Catalyst Partners is a growth equity and venture capital firm that invests in exceptional entrepreneurs who are building the technology-based companies that will lead inno...

Catalyst Advisors

Catalyst Advisors is a premier executive search firm devoted to finding exceptional boardroom and executive leaders for innovative healthcare and bioscience companies, including t...

Access Communications, LLC

Access Communications, LLC, (Access) is a premier strategic health care communications agency network comprised of 5 distinct organizations--Access Communications, Fusion Medical Communications, MedAc...

More Information about "Catalyst Communications" on BioPortfolio

We have published hundreds of Catalyst Communications news stories on BioPortfolio along with dozens of Catalyst Communications Clinical Trials and PubMed Articles about Catalyst Communications for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Catalyst Communications Companies in our database. You can also find out about relevant Catalyst Communications Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record